Elucidating a Tumor-Selective Nanoparticle Delivery Mechanism at the Colorectal Lumen–Tumor Interface for Precise Local Cancer Therapy
Juho Lee
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241 Republic of Korea
Search for more papers by this authorDongmin Kwak
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241 Republic of Korea
Search for more papers by this authorHyunwoo Kim
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241 Republic of Korea
Search for more papers by this authorMuneeb Ullah
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241 Republic of Korea
Search for more papers by this authorJihyun Kim
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241 Republic of Korea
Search for more papers by this authorMuhammad Naeem
Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, Punjab, 46000 Pakistan
Search for more papers by this authorSeonghwan Hwang
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241 Republic of Korea
Search for more papers by this authorEunok Im
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241 Republic of Korea
Search for more papers by this authorIn-Soo Yoon
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241 Republic of Korea
Search for more papers by this authorYunjin Jung
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241 Republic of Korea
Search for more papers by this authorCorresponding Author
Jin-Wook Yoo
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241 Republic of Korea
E-mail: [email protected]
Search for more papers by this authorJuho Lee
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241 Republic of Korea
Search for more papers by this authorDongmin Kwak
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241 Republic of Korea
Search for more papers by this authorHyunwoo Kim
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241 Republic of Korea
Search for more papers by this authorMuneeb Ullah
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241 Republic of Korea
Search for more papers by this authorJihyun Kim
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241 Republic of Korea
Search for more papers by this authorMuhammad Naeem
Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, Punjab, 46000 Pakistan
Search for more papers by this authorSeonghwan Hwang
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241 Republic of Korea
Search for more papers by this authorEunok Im
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241 Republic of Korea
Search for more papers by this authorIn-Soo Yoon
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241 Republic of Korea
Search for more papers by this authorYunjin Jung
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241 Republic of Korea
Search for more papers by this authorCorresponding Author
Jin-Wook Yoo
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241 Republic of Korea
E-mail: [email protected]
Search for more papers by this authorAbstract
Although various colorectal cancer (CRC)-targeted nanoparticles have been developed to selectively deliver anticancer agents to tumor tissues, severe off-target side effects still persist due to unwanted systemic nanoparticle distribution, limiting the therapeutic outcome. Here, by elucidating a tumor-selective nanoparticle delivery mechanism occurring at the colorectal lumen–tumor interface, an alternative CRC-targeted delivery route is proposed, which enables highly tumor-selective delivery without systemic distribution, through direct drug delivery from the outside of the body (colorectal lumen) to tumors in the colorectum. Owing to the presence of accessible tumor-specific receptors such as CD44 at the colorectal lumen–tumor interface, but not at the colorectal lumen–normal tissue interface, colorectal luminal surface (CLS)-targeting ligand-functionalized nanoparticles selectively accumulate in CRC tissues without systemic distribution, resulting in successful local CRC therapy. The findings suggest that CLS-targeted lumen-to-tumor delivery can be a suitable strategy for highly CRC-specific drug delivery for precise local CRC therapy.
Conflict of Interest
The authors declare no conflict of interest.
Open Research
Data Availability Statement
Data are available in the article and Supporting Information.
Supporting Information
Filename | Description |
---|---|
smll202409994-sup-0001-SupMat.docx4.9 MB | Supporting Information |
smll202409994-sup-0002-VideoS1.mp46 MB | Supplemental Video 1 |
smll202409994-sup-0003-VideoS2.mp45.2 MB | Supplemental Video 2 |
smll202409994-sup-0004-VideoS3.mp46.1 MB | Supplemental Video 3 |
smll202409994-sup-0005-VideoS4.mp410.7 MB | Supplemental Video 4 |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1M. Arnold, M. S. Sierra, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Gut 2017, 66, 683.
- 2A. Cervantes, R. Adam, S. Roselló, D. Arnold, N. Normanno, J. Taïeb, J. Seligmann, T. De Baere, P. Osterlund, T. Yoshino, Ann. Oncol. 2023, 34, 10.
- 3S. Cassidy, B. A. Syed, Nat. Rev. Drug Discovery 2017, 16, 525.
- 4P.-C. Chen, D. Yii, H.-C. Tsai, V. R. Parasuraman, A. Prasannan, C.-Y. Kao, J.-Y. Lai, React. Funct. Polym. 2019, 145, 104238.
- 5K. Liu, Z.-q. Wang, S.-j. Wang, P. Liu, Y.-h. Qin, Y. Ma, X.-C. Li, Z.-J. Huo, Int. J. Nanomed. 2015, 10, 6445.
- 6R. R. Love, H. Leventhal, D. V. Easterling, D. R. Nerenz, Cancer 1989, 63, 604.
10.1002/1097-0142(19890201)63:3<604::AID-CNCR2820630334>3.0.CO;2-2 CAS PubMed Web of Science® Google Scholar
- 7R. Minhajat, T. Harjianti, I. C. Islam, S. Winarta, Y. N. Liyadi, N. P. Bamatraf, R. Amanuddin, Ann. Med. Surg. 2023, 85, 3931.
- 8B. A. Cisterna, N. Kamaly, W. I. Choi, A. Tavakkoli, O. C. Farokhzad, C. Vilos, Nanomedicine 2016, 11, 2443.
- 9K. Y. Choi, H. Chung, K. H. Min, H. Y. Yoon, K. Kim, J. H. Park, I. C. Kwon, S. Y. Jeong, Biomaterials 2010, 31, 106.
- 10Y. H. Bae, K. Park, J. Control Release 2011, 153, 198.
- 11L. Poláková, J. Širc, R. Hobzová, A.-I. Cocârță, E. Heřmánková, Int. J. Pharm. 2019, 558, 268.
- 12F. u. Din, J. Y. Choi, D. W. Kim, O. Mustapha, D. S. Kim, R. K. Thapa, S. K. Ku, Y. S. Youn, K. T. Oh, C. S. Yong, Drug Delivery 2017, 24, 502.
- 13J. B. Wolinsky, Y. L. Colson, M. W. Grinstaff, J. Controlled Release 2012, 159, 14.
- 14E. Neri, P. Giusti, L. Battolla, P. Vagli, P. Boraschi, R. Lencioni, D. Caramella, C. Bartolozzi, Radiology 2002, 223, 615.
- 15T. Takahashi, H. Mizusawa, T. Kato, T. Yamaguchi, Am. J. Surg. 1988, 156, 58.
- 16L.-L. Wang, W.-S. Zheng, S.-H. Chen, X.-Q. Fang, PLoS One 2013, 8, e71037.
- 17M.-Y. Shen, T.-I. Liu, T.-W. Yu, R. Kv, W.-H. Chiang, Y.-C. Tsai, H.-H. Chen, S.-C. Lin, H.-C. Chiu, Biomaterials 2019, 197, 86.
- 18J. Lee, J. Bae, D. Kwak, H. Kim, J. Kim, S. P. Hlaing, A. Saparbayeva, E. H. Lee, I.-S. Yoon, M.-S. Kim, Int. J. Pharm. 2022, 630, 122443.
- 19R. Zhao, S. Du, Y. Liu, C. Lv, Y. Song, X. Chen, B. Zhang, D. Li, S. Gao, W. Cui, Theranostics 2020, 10, 3594.
- 20N. Bertrand, J. Wu, X. Xu, N. Kamaly, O. C. Farokhzad, Adv. Drug Delivery Rev. 2014, 66, 2.
- 21S. A. Dilliard, D. J. Siegwart, Nat. Rev. Mater. 2023, 8, 282.
- 22J. Li, Q. Wang, G. Xia, N. Adilijiang, Y. Li, Z. Hou, Z. Fan, J. Li, Pharmaceutics 2023, 15, 2233.
- 23P. Ziranu, A. Pretta, V. Aimola, F. Cau, S. Mariani, A. P. D'Agata, C. Codipietro, D. Rizzo, V. Dell'Utri, G. Sanna, Cancers 2024, 16, 1569.
- 24M. Schneider, J. Huber, B. Hadaschik, G. M. Siegers, H.-H. Fiebig, J. Schüler, BMC Cancer 2012, 12, 96.
- 25J. Chou, M. P. Fitzgibbon, C.-L. L. Mortales, A. M. H. Towlerton, M. P. Upton, R. S. Yeung, M. W. McIntosh, E. H. Warren, PLoS One 2013, 8, e79874.
- 26B. M. Boman, V. Viswanathan, C. O. B. Facey, J. Z. Fields, J. W. Stave, Cancer Biol. Therapy 2023, 24, 2195363.
- 27G. M. H. Birchenough, M. E. V. Johansson, Science 2020, 370, 402.
- 28R. Nunes, B. Sarmento, J. das Neves, J. Controlled Release 2014, 194, 278.
- 29S. I. Nour El Hoda, W. M. Sharaf, D. O. Helmy, M. M. Zaki, M. A. Badawi, A. S. A. Soliman, Open Access Maced. J. Med. Sci. 2016, 4, 543.
- 30G. Mattheolabakis, L. Milane, A. Singh, M. M. Amiji, J. Drug Targeting 2015, 23, 605.
- 31R. Nunes, F. Araújo, J. Tavares, B. Sarmento, J. das Neves, Eur. J. Pharm. Biopharm. 2018, 130, 200.
- 32H. Tian, Z. He, C. Sun, C. Yang, P. Zhao, L. Liu, K. W. Leong, H. Q. Mao, Z. Liu, Y. Chen, Adv. Healthcare Mater. 2018, 7, 1800285.
- 33W. Shan, X. Zhu, M. Liu, L. Li, J. Zhong, W. Sun, Z. Zhang, Y. Huang, ACS Nano 2015, 9, 2345.
- 34Z. He, Z. Liu, H. Tian, Y. Hu, L. Liu, K. W. Leong, H.-Q. Mao, Y. Chen, Nanoscale 2018, 10, 3307.
- 35X.-L. Wang, W.-Z. Zhao, J.-Z. Fan, L.-C. Jia, Y.-N. Lu, L.-H. Zeng, Y.-Y. Lv, X.-Y. Sun, Molecules 2022, 27, 2419.
- 36J. Su, C. Wu, J. Zou, X. Wang, K. Yang, J. Liu, Z. Wu, W. Zhang, J. Controlled Release 2024, 372, 69.
- 37P. Kesharwani, R. Chadar, A. Sheikh, W. Y. Rizg, A. Y. Safhi, Front. Pharmacol. 2022, 12, 800481.
- 38O. Young, N. Ngo, L. Lin, L. Stanbery, J. F. Creeden, D. Hamouda, J. Nemunaitis, Curr. Probl. Cancer 2023, 47, 100917.
- 39R. A. Hutchinson, R. A. Adams, D. G. McArt, M. Salto-Tellez, B. Jasani, P. W. Hamilton, J. Transl. Med. 2015, 13, 217.
- 40Y. Gao, W. Qiu, M. Liang, X. Ma, M. Ye, P. Xue, Y. Kang, J. Deng, Z. Xu, Acta Biomater. 2022, 147, 299.
- 41Y. Shen, X. Li, D. Dong, B. Zhang, Y. Xue, P. Shang, Am. J. Cancer Res. 2018, 8, 916.
- 42K. Wang, R. Shen, T. Meng, F. Hu, H. Yuan, Molecules 2022, 27, 2981.
- 43A. Zeb, M. Gul, T.-T.-L. Nguyen, H.-J. Maeng, J. Pharm. Invest. 2023, 53, 743.
- 44M. Boegh, H. M. Nielsen, Basic Clin. Pharmacol. Toxicol. 2015, 116, 179.
- 45K. Maisel, L. Ensign, M. Reddy, R. Cone, J. Hanes, J. Controlled Release 2015, 197, 48.
- 46S. P. Bandi, Y. S. Kumbhar, V. V. K. Venuganti, J. Nanopart. Res. 2020, 22, 62.
- 47A. W. Basit, Drugs 2005, 65, 1991.
- 48J. G. Hardy, S. W. Lee, A. G. Clark, J. R. Reynolds, Int. J. Pharm. 1986, 31, 151.
- 49Y. Liu, G. Yang, S. Jin, L. Xu, C. X. Zhao, ChemPlusChem 2020, 85, 2143.
- 50Y. Eygeris, S. Patel, A. Jozic, G. Sahay, Nano Lett. 2020, 20, 4543.
- 51S. Hong, D. W. Choi, H. N. Kim, C. G. Park, W. Lee, H. H. Park, Pharmaceutics 2020, 12, 604.
- 52J. O. Eloy, R. Petrilli, L. N. F. Trevizan, M. Chorilli, Colloids Surf., B 2017, 159, 454.
- 53A. C. Marques, P. J. Costa, S. Velho, M. H. Amaral, J. Controlled Release 2020, 320, 180.
- 54H. M. Jung, C. H. Kim, J.-E. Seo, Y. T. Goo, S. H. Hong, M. J. Kang, S. Lee, Y. W. Choi, J. Pharm. Invest. 2024, 54, 61.
- 55B. Song, C.-W. Cho, J. Pharm. Invest. 2024, 54, 249.
- 56X. Yuan, W. Ji, S. Chen, Y. Bao, S. Tan, S. Lu, K. Wu, Q. Chu, Int. J. Nanomed. 2016, 11, 6229.
- 57A. Saparbayeva, J. Lee, S. P. Hlaing, J. Kim, D. Kwak, H. Kim, E. H. Lee, S. Hwang, M.-S. Kim, H. R. Moon, Arch. Pharm. Res. 2023, 46, 646.
- 58L. B. Vong, Y. Nagasaki, Mol. Pharmaceutics 2016, 13, 449.
- 59C. M. Park, P. E. Reid, D. C. Walker, B. R. MacPherson, J. Microsc. 1987, 145, 115.
- 60J. M. M. Terwogt, B. Nuijen, W. W. T. B. Huinink, J. H. Beijnen, Cancer Treat. Rev. 1997, 23, 87.
- 61C. Becker, M. C. Fantini, M. F. Neurath, Nat. Protoc. 2006, 1, 2900.
- 62C. Becker, M. C. Fantini, S. Wirtz, A. Nikolaev, R. Kiesslich, H.-A. Lehr, P. R. Galle, M. F. Neurath, Gut 2005, 54, 950.